TABLE 3.

Conclusions and recommendations for statin usage to mitigate COVID-19.

Conclusions
1	Antecedent statin use is associated with a lower risk of severity and mortality
2	Severity decreased and mortality dropped for those on statins
3	Prior chronic use of statin and non-ICU patients fared better
4	Benefits were seen in COVID-19 patients with high cholesterol and inflammation after COVID-19 diagnosis lowered mortality risk
Recommendations
1	Continue statin in patients with COVID-19 who were already on them
2	Continue statin in CVD and Lipidemia patients without COVID-19
3	Initiate statin therapies among patients at risk of COVID-19
4	Initiate of statin therapies among patients hospitalized with COVID-19
5	Initiate statin therapies among diabetics, especially minorities